Filter
1437
Text search:
CD4
Featured
129
399
Language
Document type
939
231
130
48
32
25
19
4
3
3
2
Countries / Regions
89
53
46
41
36
31
30
27
24
22
22
21
21
21
20
19
19
18
18
18
16
15
15
14
13
13
12
12
11
11
10
10
10
10
9
9
9
8
8
8
8
7
7
7
6
6
6
6
6
6
5
5
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
700
126
45
39
25
14
12
Toolboxes
346
228
86
35
15
14
12
11
11
11
6
6
6
5
3
3
2
2
2
2
2
2
1
1
Accessed August 31,2017
Advanced HIV disease (defined in persons living with HIV with a CD4 cell count of <200cells/mm3 or presenting with a WHO Stage 3/4 AIDS-defining illness) poses a challenge to many countries globally and is responsible for significant mortality and morbidity among peopl
...
Archives of Medicine vo.7 no.5:10
Individuals infected with human immunodeficiency virus (HIV) often develop
multiple complications and comorbidities, among them, opportunistic infections.
The highest incidence of opportunistic infections was reported in the group
of patients with
...
J Infect Dev Ctries 2023; 17(7):1022-1029. doi:10.3855/jidc.15105
Opportunistic co-infections are more prevalent in HIV-infected patients with a CD4 + cell count of < 200 cells/mm3, poor drug adherence, and also associated with the occupation. So, regular examination
...
The target audience for this guideline is primarily for health care providers nurses, doctors, social workers and other people involved in HIV response in Rwanda so that they are capable of offering quality care services to patients over a long time. The new National Guidelines for Prevention and Ma
...
Front. Immunol. 12:620657. doi: 10.3389/fimmu.2021.620657.
HIV-1 infection disproportionately affects women in sub-Saharan Africa, where areas of high HIV-1 prevalence and Schistosoma haematobium endemicity largely overlap. Female genital schistosomiasis (FGS), caused most frequently by S. haemato
...
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 (2025 interim update)
The purpose of the 2025 interim update of the guidelines was to update our recommendations based on new evidence since the last update, including: (i) incorporating new evidence related to injectable therapy including frequency of viral load monitoring and use of long-acting cabotegravir/rilpivirine
...
Objective: The study aimed to describe the current epidemiological, clinical and immunological profile of newly
detected HIV - positive patients in Northern Benin by 2016. Methods: It was a prospective study conducted from May 2 to
October 31, 2016 on three main sites of care of people living with
...
Информация о диагностике туберкулеза для больных и их родственников.
Информация о туберкулезной терапии для больных и их родственников
Руководство по инвестициям Глобального фонда для стран Восточной Европы и Центральной Азии. В ходе разработки Руководства Глобальный фонд стремился учесть мнени
...
Вы держите в руках брошюру, которую подготовили для вас специалисты МНПЦ борьбы с туберкулёзом.Она поможет вам узнать:
•о ВИЧ-инфекции и вирусе иммунодефицита чел
...
Thirty-three years after its discovery, the Human Immunodeficiency Virus (HIV), responsible for the AIDS pandemic, remains a major public health problem despite advanced researches providing better diagnostic and therapeutic tools. The virus targets especially CD4+ T cells, leading to deficiency of
...
СТАНДАРТ МЕДИЧНОЇ ДОПОМОГИ.
These clinical guidelines, released by the Ukraine Ministry of Health in 2025, include the latest recommendations for HIV services, including oral PrEP and injectable cabotegravir (CAB) for PrEP.
Advanced Clinical Care (ACC) Live Tutorial session 22 August 2024